Floatz logo

PEGASPARGASE

Carcinoma

Pfizerprotein_peptidePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
81/ 100

Competitive context

33 Active assets in the Carcinoma cohort.

Asset / SponsorPhaseRating
Carboplatin
AstraZeneca
Phase 4BB
Docetaxel
Merck Sharp & Dohme LLC
Phase 3BB
Osimertinib
AstraZeneca
Phase 3BB
ALBUMIN AGGREGATED
Sirtex Medical
Phase 4BB
Crizotinib
Ariad Pharmaceuticals
Phase 3BB

View all 50 →

Same molecule, other indications

PEGASPARGASE is also rated in:

B-cell childhood acute lymphoblastic leukemiaDormant
A
Indicative ·
80 / 100
View asset →
Adult Acute Lymphocytic LeukemiaDormant
BBB
Indicative ·
77 / 100
View asset →
extranodal nasal NK/T cell lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →